• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用新型酶促线性 DNA 生产慢病毒载体。

Production of lentiviral vectors using novel, enzymatically produced, linear DNA.

机构信息

Gene Transfer Technology Group, Institute for Women's Health, University College London, London, UK.

Dubowitz Neuromuscular Centre, Molecular Neurosciences Section, Developmental Neurosciences Programme, UCL Great Ormond Street Institute of Child Health, London, UK.

出版信息

Gene Ther. 2019 Apr;26(3-4):86-92. doi: 10.1038/s41434-018-0056-1. Epub 2019 Jan 14.

DOI:10.1038/s41434-018-0056-1
PMID:30643205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6760675/
Abstract

The manufacture of large quantities of high-quality DNA is a major bottleneck in the production of viral vectors for gene therapy. Touchlight Genetics has developed a proprietary abiological technology that addresses the major issues in commercial DNA supply. The technology uses 'rolling-circle' amplification to produce large quantities of concatameric DNA that is then processed to create closed linear double-stranded DNA by enzymatic digestion. This novel form of DNA, Doggybone™ DNA (dbDNA™), is structurally distinct from plasmid DNA. Here we compare lentiviral vectors production from dbDNA™ and plasmid DNA. Lentiviral vectors were administered to neonatal mice via intracerebroventricular injection. Luciferase expression was quantified in conscious mice continually by whole-body bioluminescent imaging. We observed long-term luciferase expression using dbDNA™-derived vectors, which was comparable to plasmid-derived lentivirus vectors. Here we have demonstrated that functional lentiviral vectors can be produced using the novel dbDNA™ configuration for delivery in vitro and in vivo. Importantly, this could enable lentiviral vector packaging of complex DNA sequences that have previously been incompatible with bacterial propagation systems, as dbDNA™ technology could circumvent such restrictions through its phi29-based rolling-circle amplification.

摘要

大量高质量 DNA 的制造是基因治疗中病毒载体生产的主要瓶颈。Touchlight Genetics 开发了一种专有的非生物学技术,解决了商业 DNA 供应中的主要问题。该技术使用“滚环”扩增来产生大量串联 DNA,然后通过酶消化处理将其加工成闭合的线性双链 DNA。这种新型 DNA,即犬骨 DNA(dbDNA),在结构上与质粒 DNA 不同。在这里,我们比较了来自 dbDNA 和质粒 DNA 的慢病毒载体生产。慢病毒载体通过脑室内注射递送至新生小鼠。通过全身生物发光成像在有意识的小鼠中连续定量检测荧光素酶表达。我们观察到使用 dbDNA 衍生载体的长期荧光素酶表达,与质粒衍生的慢病毒载体相当。在这里,我们已经证明可以使用新型 dbDNA 配置来生产功能性慢病毒载体,用于体外和体内递送。重要的是,这可以使以前与细菌繁殖系统不兼容的复杂 DNA 序列能够进行慢病毒载体包装,因为 dbDNA 技术可以通过其基于 phi29 的滚环扩增来规避此类限制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/2f57e656290e/41434_2018_56_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/08d354b4ad4f/41434_2018_56_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/f6f219513d12/41434_2018_56_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/9d9735725bd6/41434_2018_56_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/104de489cc87/41434_2018_56_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/2f57e656290e/41434_2018_56_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/08d354b4ad4f/41434_2018_56_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/f6f219513d12/41434_2018_56_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/9d9735725bd6/41434_2018_56_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/104de489cc87/41434_2018_56_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bef/6760675/2f57e656290e/41434_2018_56_Fig5_HTML.jpg

相似文献

1
Production of lentiviral vectors using novel, enzymatically produced, linear DNA.使用新型酶促线性 DNA 生产慢病毒载体。
Gene Ther. 2019 Apr;26(3-4):86-92. doi: 10.1038/s41434-018-0056-1. Epub 2019 Jan 14.
2
Enzymatically amplified linear dbDNA as a rapid and scalable solution to industrial lentiviral vector manufacturing.酶放大线性 dbDNA 作为一种快速且可扩展的工业慢病毒载体生产解决方案。
Gene Ther. 2023 Feb;30(1-2):122-131. doi: 10.1038/s41434-022-00343-4. Epub 2022 May 24.
3
Production of lentiviral vectors for transducing cells from the central nervous system.用于转导中枢神经系统细胞的慢病毒载体的生产。
J Vis Exp. 2012 May 24(63):e4031. doi: 10.3791/4031.
4
High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.用于基因和细胞治疗的滚瓶中基于HIV的慢病毒载体的高滴度生产。
Methods Mol Biol. 2019;1879:323-345. doi: 10.1007/7651_2018_150.
5
Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.包装基于HIV或FIV的慢病毒载体表达构建体并转导VSV-G假型化病毒颗粒。
J Vis Exp. 2012 Apr 8(62):e3171. doi: 10.3791/3171.
6
CAR T Cell Generation by Transposition from Linear Doggybone DNA Vectors Requires Transposon DNA-Flanking Regions.通过从线性狗骨状DNA载体转座产生CAR T细胞需要转座子DNA侧翼区域。
Mol Ther Methods Clin Dev. 2020 Jan 16;17:359-368. doi: 10.1016/j.omtm.2019.12.020. eCollection 2020 Jun 12.
7
DNA vector-based RNA interference to study gene function in cancer.基于DNA载体的RNA干扰技术在癌症基因功能研究中的应用
J Vis Exp. 2012 Jun 4(64):e4129. doi: 10.3791/4129.
8
[Investigation of Lentiviral Vectors Based Integrin β8 RNAi System in Neonatal Rats' Brain].基于慢病毒载体的整合素β8 RNA干扰系统在新生大鼠脑内的研究
Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 May;49(3):325-330.
9
Large-scale production means for the manufacturing of lentiviral vectors.用于慢病毒载体制造的大规模生产手段。
Curr Gene Ther. 2010 Dec;10(6):474-86. doi: 10.2174/156652310793797748.
10
A guide in lentiviral vector production for hard-to-transfect cells, using cardiac-derived c-kit expressing cells as a model system.慢病毒载体生产指南,适用于难转染细胞,以心脏来源的表达 c-kit 的细胞作为模型系统。
Sci Rep. 2021 Sep 28;11(1):19265. doi: 10.1038/s41598-021-98657-7.

引用本文的文献

1
New dual inducible cellular model to investigate temporal control of oncogenic cooperating genes.新型双重诱导细胞模型,用于研究致癌基因协同作用的时间控制。
Sci Rep. 2024 Sep 5;14(1):20773. doi: 10.1038/s41598-024-71227-3.
2
Designing of an extract production protocol for industrial application of cell-free protein synthesis technology: Building from a current best practice to a quality by design approach.为无细胞蛋白质合成技术的工业应用设计提取物生产方案:从当前最佳实践到质量源于设计方法的构建。
Eng Biol. 2023 Dec 6;7(1-4):1-17. doi: 10.1049/enb2.12029. eCollection 2023 Dec.
3
Non-Invasive Vaccines: Challenges in Formulation and Vaccine Adjuvants.

本文引用的文献

1
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model.线性犬骨 DNA 疫苗在临床前模型中诱导与传统质粒 DNA 相似的免疫反应,而不受 TLR9 的免疫识别影响。
Cancer Immunol Immunother. 2018 Apr;67(4):627-638. doi: 10.1007/s00262-017-2111-y. Epub 2018 Jan 12.
2
Continual conscious bioluminescent imaging in freely moving somatotransgenic mice.在自由活动的躯体转基因小鼠中进行持续的有意识生物发光成像。
Sci Rep. 2017 Jul 25;7(1):6374. doi: 10.1038/s41598-017-06696-w.
3
Eliminating HIV-1 Packaging Sequences from Lentiviral Vector Proviruses Enhances Safety and Expedites Gene Transfer for Gene Therapy.
非侵入性疫苗:制剂和疫苗佐剂方面的挑战
Pharmaceutics. 2023 Aug 9;15(8):2114. doi: 10.3390/pharmaceutics15082114.
4
Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy.货舱偷渡者:基因治疗用 rAAV 制剂中的污染核酸。
Mol Ther. 2023 Oct 4;31(10):2826-2838. doi: 10.1016/j.ymthe.2023.07.025. Epub 2023 Aug 2.
5
Genomic investigations of unexplained acute hepatitis in children.儿童不明原因急性肝炎的基因组学研究。
Nature. 2023 May;617(7961):564-573. doi: 10.1038/s41586-023-06003-w. Epub 2023 Mar 30.
6
The TelN/tos-assisted precise targeting of chromosome segments (TAPE).TelN/tos 辅助的染色体片段精确靶向(TAPE)。
J Adv Res. 2022 Nov;41:169-177. doi: 10.1016/j.jare.2022.01.017. Epub 2022 Feb 3.
7
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)犬骨DNA疫苗可产生交叉变异中和抗体,并在新冠病毒疾病(COVID-19)动物模型中具有保护作用。
Vaccines (Basel). 2022 Jul 9;10(7):1104. doi: 10.3390/vaccines10071104.
8
Enzymatically amplified linear dbDNA as a rapid and scalable solution to industrial lentiviral vector manufacturing.酶放大线性 dbDNA 作为一种快速且可扩展的工业慢病毒载体生产解决方案。
Gene Ther. 2023 Feb;30(1-2):122-131. doi: 10.1038/s41434-022-00343-4. Epub 2022 May 24.
9
Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.用于呼吸道 COVID-19 疾病的 RNAi 治疗的纳米颗粒递送平台。
Int J Mol Sci. 2022 Feb 22;23(5):2408. doi: 10.3390/ijms23052408.
10
A brief review on DNA vaccines in the era of COVID-19.新冠疫情时代DNA疫苗的简要综述
Future Virol. 2021 Nov. doi: 10.2217/fvl-2021-0170. Epub 2021 Nov 26.
从慢病毒载体前病毒中去除HIV-1包装序列可提高安全性并加速基因治疗中的基因转移。
Mol Ther. 2017 Aug 2;25(8):1790-1804. doi: 10.1016/j.ymthe.2017.04.028. Epub 2017 May 24.
4
Sequence-Modified Antibiotic Resistance Genes Provide Sustained Plasmid-Mediated Transgene Expression in Mammals.序列修饰的抗生素抗性基因在哺乳动物中提供持续的质粒介导的转基因表达。
Mol Ther. 2017 May 3;25(5):1187-1198. doi: 10.1016/j.ymthe.2017.03.003. Epub 2017 Mar 30.
5
Lentiviral vectors can be used for full-length dystrophin gene therapy.慢病毒载体可用于全长肌营养不良蛋白基因治疗。
Sci Rep. 2017 Mar 6;7(1):79. doi: 10.1038/s41598-017-00152-5.
6
The Nav channel bench series: Plasmid preparation.Nav通道实验台系列:质粒制备。
MethodsX. 2014 Feb 1;1:6-11. doi: 10.1016/j.mex.2014.01.002. eCollection 2014.
7
In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters.利用组织特异性转录因子激活的荧光素酶报告基因进行体内生物成像。
Sci Rep. 2015 Jul 3;5:11842. doi: 10.1038/srep11842.
8
Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.新型合成质粒和“狗骨”DNA疫苗可诱导中和抗体,并为小鼠抵御致命性流感攻击提供保护。
Hum Vaccin Immunother. 2015;11(8):1972-82. doi: 10.1080/21645515.2015.1022008.
9
Evidence for contribution of CD4+ CD25+ regulatory T cells in maintaining immune tolerance to human factor IX following perinatal adenovirus vector delivery.证据表明,围产期腺病毒载体递送后,CD4+CD25+调节性 T 细胞有助于维持对人凝血因子 IX 的免疫耐受。
J Immunol Res. 2015;2015:397879. doi: 10.1155/2015/397879. Epub 2015 Jan 31.
10
Comparative analysis of enzymatically produced novel linear DNA constructs with plasmids for use as DNA vaccines.酶促产生的新型线性DNA构建体与用作DNA疫苗的质粒的比较分析。
Gene Ther. 2014 Jul;21(7):645-52. doi: 10.1038/gt.2014.37. Epub 2014 May 15.